LifeScience Biologics
BioDlink Supports Junshi Biosciences in Achieving IND Approval for JS212, Its First Bispecific ADC
BioDlink congratulates Junshi Biosciences on receiving IND approval from China's NMPA for JS212, the company...
May 09, 2025 | News
Nordic Bioscience and Roche Launch Elecsys PRO-C3 Test to Advance Liver Fibrosis Assessment on cobas Analyzers
Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used w...
May 09, 2025 | News
India to Gain Faster, Affordable Access to CAR T Therapy as NKure Therapeutics Partners with CRISPR Therapeutics
CTX112™ is an off-the-shelf investigational therapy, offering the potential for faster patient access compared to current CAR T treatments....
May 08, 2025 | News
Ajinomoto and RIBOMIC Advance Next-Gen Aptamer Therapeutics with Extended Half-Life Using AJICAP® Technology
Ajinomoto Co., Inc. has been conducting joint research* with RIBOMIC Inc. (President: Yoshikazu Nakamura, Headquarters: Minato-ku, Tokyo, hereinafter refer...
May 07, 2025 | News
Waters Integrates MALS into Empower™ Software to Accelerate Biologics QC and Slash Validation Time
Saves up to six months on compliant software validation in biopharmaceutical quality control. Reduces analysis time for biotherapeutic peptides and prot...
May 07, 2025 | News
Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma
Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...
May 06, 2025 | News
Fangzhou Launches Otsuka’s Iclusig® Online for Leukemia Care in China
Fangzhou Inc. , a leader in Internet healthcare solutions, announced the availability of Otsuka Pharmaceutical's third-generation tyrosine kinase inhi...
May 06, 2025 | News
Nutshell Therapeutics Receives FDA IND Clearance for First-in-Human Trial of NTS071 Targeting p53 Y220C Mutation
Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical ...
May 05, 2025 | News
Genmab to Submit sBLA for Epcoritamab-R2 Combination in Relapsed/Refractory Follicular Lymphoma Following Positive Phase 3 Data
--Genmab A/S (Nasdaq: GMAB) announced its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to t...
May 05, 2025 | Regulatory
AstraZeneca’s BREZTRI AEROSPHERE Demonstrates Significant Lung Function Gains in Phase III Asthma Trials
Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose tripl...
May 05, 2025 | News
S&E bio Receives MFDS Approval for Korea’s First Clinical Trial of Exosome-Based Stroke Therapy
S&E bio Co., Ltd., a biotechnology company specializing in exosomal microRNA-based therapies, has received approval from Korea's Ministry of Food...
May 01, 2025 | News
Asimov and Cytiva Unite to Fast-Track Complex Biologics Production
Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...
April 30, 2025 | News
Innovent Biologics Doses First Patient in Global Phase 1 Trial of IBI3020, a First-in-Class Dual-Payload CEACAM5 ADC
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment ...
April 30, 2025 | News
RoosterBio and Thermo Fisher Partner to Accelerate Cell and Exosome Therapy Development
RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services,&n...
April 30, 2025 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
